Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

3.2%

2 terminated/withdrawn out of 62 trials

Success Rate

93.3%

+6.8% vs industry average

Late-Stage Pipeline

5%

3 trials in Phase 3/4

Results Transparency

11%

3 of 28 completed trials have results

Key Signals

7 recruiting3 with results

Enrollment Performance

Analytics

N/A
26(57.8%)
Phase 2
9(20.0%)
Phase 1
6(13.3%)
Phase 3
3(6.7%)
Early Phase 1
1(2.2%)
45Total
N/A(26)
Phase 2(9)
Phase 1(6)
Phase 3(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (62)

Showing 20 of 62 trials
NCT04071704Completed

Assessing Health-related Quality of Life in Sarcoma Patients

Role: collaborator

NCT06446882Not ApplicableRecruiting

Diagnostic HER2DX-guided Treatment for Patients wIth Early-stage HER2-positive Breast Cancer

Role: collaborator

NCT04343950Not ApplicableCompleted

SMS Messaging as a Tool to Improve Cancer Screening Programs

Role: lead

NCT02834637Phase 3Active Not Recruiting

A Dose Reduction Immunobridging and Safety Study of Two HPV Vaccines in Tanzanian Girls

Role: collaborator

NCT07058207Not ApplicableRecruiting

Weight Management in Obese Cancer Patients During Curative Active Treatment

Role: collaborator

NCT07039994Not ApplicableRecruiting

Early Palliative Care in Patients With Advanced Lung Cancer Using an e-Health Ecosystem

Role: collaborator

NCT06932276Not ApplicableRecruiting

Implementing an Adapted Smoke-free Homes Intervention in Spain

Role: lead

NCT06718322Not ApplicableEnrolling By Invitation

PIECES - Towards Large-Scale Adaptation and Tailored Implementation of Primary Cancer Prevention Programs

Role: collaborator

NCT06420609Not ApplicableActive Not Recruiting

Efficacy of a Proactive Approach to Death Thoughts in People with Advanced Cancer

Role: collaborator

NCT06605417Recruiting

Understanding the Transition from Normal Melanocytes to Nevus to Melanoma

Role: collaborator

NCT05933876Recruiting

The Impact of Radiotherapy on Oligometastatic Cancer

Role: collaborator

NCT06646315Not ApplicableCompleted

Early Versus Standard Care in Cancer Patients in Phase 1 Clinical Trials

Role: lead

NCT06104579Completed

Concordance Between Monitoring Systems for Organ/Space Surgical Site Infections in Rectal Surgery

Role: collaborator

NCT06382415Completed

Organ/Space Surgical Site Infection and Recurrence and Survival in Rectal Cancer Surgery

Role: collaborator

NCT06103318Not ApplicableNot Yet Recruiting

eHealth Interventions for Breast Cancer Cognitive Impairment

Role: lead

NCT04372459Not ApplicableCompleted

Online Psychosocial Cancer Screening, Monitoring and Stepped Treatment in Cancer Survivors

Role: lead

NCT06234735Not ApplicableNot Yet Recruiting

Physical Activity Behavioral Change Intervention in Lung Cancer

Role: collaborator

NCT03297346Not ApplicableCompleted

Early Detection of Cardiovascular Changes After Radiotherapy for Breast Cancer

Role: collaborator

NCT05497973Not ApplicableUnknown

Psychosocial eHealth in Advanced Lung Cancer

Role: lead

NCT05912062Unknown

Early On-treatment Transcriptional Profiling as Predictor of Response in Early-stage HER2-positive Breast Cancer

Role: lead